@article{article, title  = {{Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo‐controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ)}},

 publisher = {{Wiley }},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/125021 }},

 year = {{2018}},

 month = {{5}},

 author = {{de Bruin-Weller M and Thaçi D and Smith CH and Reich K and Cork M and Radin A and Zhang Q and Akinlade B and Gadkari A and Eckert L and Hultsch T et al}},

 doi = {{10.1111/bjd.16156}},

 volume = {{178}},

 journal = {{British Journal of Dermatology }},

 issue = {{5}},

 pages = {{1083-1101}},

 note = {{Accessed on 2025/11/05}}}